No quarterly revenue total was found in Glucotrack, Inc.'s SEC filings.
Glucotrack, Inc. (GCTK) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. As of Jun 30, 2026 it held $1.1 million in cash and investments and $19,000 in total debt.
Revenue
—
Net income
$-3.81M
+19.8% vs year-ago quarter
Operating cash flow
$-3.62M
+3.4% vs year-ago quarter
Free cash flow
$-3.96M
-13.1% vs year-ago quarter
EPS
$0.76
-92.1% vs year-ago quarter
Dividend per share
None
Shares outstanding
10.58M
+1076.2% vs year-ago quarter
Net cash
$1.10M
Q2 FY2026
Operating margin
—
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- GCTK (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Rutherford, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1506983
- Former names
- Integrity Applications, Inc. (until Dec 9, 2021)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Operating income | -$3.4M | -$4.2M | -$3.5M | -$4.3M | -$4.8M |
| Net income | -$3.8M | -$4.3M | -$3.6M | -$4.2M | -$4.8M |
| Diluted EPS | $0.76 | $2.65 | -$3.99 | $4.64 | $9.62 |
| Operating cash flow | -$3.6M | -$4.0M | -$3.9M | -$4.6M | -$3.7M |
| Free cash flow | — | — | -$4.0M | -$4.7M | -$3.7M |
| Total assets | $1.5M | $4.4M | $7.8M | $8.3M | $10.2M |
| Total liabilities | $3.2M | $5.2M | $5.0M | $5.5M | $3.3M |
| Stockholders' equity | -$1.7M | -$851,000 | $2.8M | $2.8M | $6.9M |
| Cash and investments | $1.1M | $3.9M | $7.4M | $7.9M | $9.6M |
| Total debt | $19,000 | $26,000 | $33,000 | $40,000 | $46,000 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Listing notice
|
Oct 29, 2026 | Oct 28, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Oct 28, 2026 | Oct 23, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
|
Oct 22, 2026 | Oct 22, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 19, 2026 | Oct 13, 2026 |
| 8-K/A | Amended current report | Oct 13, 2026 | Jul 9, 2026 |
| 8-K |
Current report
Material agreement
|
Sep 28, 2026 | Sep 22, 2026 |
All 495 Glucotrack, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.